Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Unrecognized SBC cost by Quarter
Unrecognized SBC cost — Stock options (historical, $M) ($M)
Vertex Pharmaceuticals Unrecognized SBC cost: $2.20M in Q4 2022, down 88.5% from a year earlier. That is the lowest of the 16 quarters on record here. No newer figure appears in the documents we track.
Where the Q4 2022 figure comes from
Source: Form 10-K (filed 2023-02-10) ↗
Reported in Form 10-K Note (Stock-based Compensation).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Unrecognized SBC cost — Stock options (historical, $M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2022 | Dec 31, 2022 | 2.20 | -88.5% | Form 10-K (filed 2023-02-10) ↗ |
| Q4 2021 | Dec 31, 2021 | 19.1 | -69.4% | Form 10-K (filed 2022-02-09) ↗ |
| Q4 2020 | Dec 31, 2020 | 62.4 | -52.1% | Form 10-K (filed 2021-02-11) ↗ |
| Q3 2020 | Sep 30, 2020 | 76.3 | -50.4% | Form 10-Q (filed 2020-10-30) ↗ |
| Q2 2020 | Jun 30, 2020 | 91.8 | -44.0% | Form 10-Q (filed 2020-07-31) ↗ |
| Q1 2020 | Mar 31, 2020 | 109 | -43.6% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | 130 | -16.3% | Form 10-K (filed 2020-02-13) ↗ |
| Q3 2019 | Sep 30, 2019 | 154 | -18.7% | Form 10-Q (filed 2019-10-31) ↗ |
| Q2 2019 | Jun 30, 2019 | 164 | -3.1% | Form 10-Q (filed 2019-08-01) ↗ |
| Q1 2019 | Mar 31, 2019 | 193 | -4.9% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 156 | +5.5% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2018 | Sep 30, 2018 | 189 | – | Form 10-Q (filed 2018-10-25) ↗ |
| Q2 2018 | Jun 30, 2018 | 169 | – | Form 10-Q (filed 2018-07-26) ↗ |
| Q1 2018 | Mar 31, 2018 | 203 | – | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2017 | Dec 31, 2017 | 147 | -6.6% | Form 10-K (filed 2018-02-15) ↗ |
| Q4 2016 | Dec 31, 2016 | 158 | – | Form 10-K (filed 2017-02-23) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Unrecognized SBC cost ($M), quarterly Q4 2016–Q4 2022 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/sbc-unrec-opt
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.